EASL Studio Podcast: YI Choice: Gene therapy for liver disease — RNA interference and beyond

from EASL Podcasts · host European Association for the Study of the Liver

Emerging therapeutics based on gene addition, editing, or silencing are expected to change the landscape of genetic liver disease.Watch this episode to find out:Which approaches exist?Where are they in terms of preclinical and clinical development?How will they be used?FacultyDr Mattias Mandorfer (Moderator)Dr Gloria Gonzalez-Aseguinolaza (Faculty)Prof. Pavel Strnad (Faculty)Prof. Man-Fung Yuen (Faculty)All EASL Studio Podcasts are available on EASL Campus.

Episode metadata supplied by the publisher feed · Published Mar 23, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

EASL Studio Podcast: YI Choice: Gene therapy for liver disease — RNA interference and beyond

0:00 29:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EASL Podcasts?

This episode is 29 minutes long.

When was this EASL Podcasts episode published?

This episode was published on March 23, 2023.

Can I download this EASL Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!